GYS1 encodes glycogen synthase 1, the muscle (and general non-hepatic) isoform of glycogen synthase and the committed, rate-limiting elongation enzyme of glycogen biosynthesis. As a retaining glycosyltransferase of family GT3 (EC 2.4.1.11), it uses UDP-glucose as the glucosyl donor to add glucose units in alpha-1,4-glycosidic linkage to the non-reducing ends of a growing glycogen chain that has been primed by glycogenin (GYG1); glycogen branching enzyme (GBE1) subsequently introduces alpha-1,6 branch points. GYS1 forms a heterooctameric complex with glycogenin (a GYS1 tetramer bound to two GYG1 dimers). Its activity is tightly regulated: it is allosterically activated by glucose-6-phosphate and inhibited by hierarchical multi-site phosphorylation of its N- and C-terminal tails (by kinases including GSK3, AMPK, casein kinase 2, PASK and DYRK2), which is reversed by glycogen-associated protein phosphatase 1 (recruited by PPP1R3 targeting subunits such as PTG/PPP1R3C). GYS1 is cytosolic and associates with glycogen particles. In humans, loss-of-function variants cause muscle glycogen storage disease 0 (GSD 0b), characterized by cardiomyopathy, exercise intolerance and risk of sudden cardiac death.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004373
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Canonical, phylogenetically inferred molecular function of glycogen synthase: it elongates glycogen chains by transferring glucose from UDP-glucose to the alpha-1,4 non-reducing end of the polymer. This is the core catalytic activity of GYS1.
Reason: The IBA is well supported by direct experimental evidence for the human enzyme and by the biochemical literature. This is the defining activity of GYS1 (EC 2.4.1.11).
Supporting Evidence:
PMID:35835870
GYS, a retaining glycosyltransferase (GT) belonging to the GT3 superfamily, catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing end of a growing polysaccharide chain, using UDP-glc as the sugar donor with the release of UDP5.
|
|
GO:0005978
glycogen biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: GYS1 is the elongation enzyme of glycogen biosynthesis, acting together with glycogenin (priming) and branching enzyme (branching). This is a core biological process for the gene.
Reason: Directly supported by experimental and structural work on human GYS1; the enzyme catalyzes the rate-limiting elongation step of glycogen synthesis.
Supporting Evidence:
PMID:35835870
Glycogen synthesis is a multistep process consisting of a priming step by GYG followed by an elongation step carried out by GYS and then a branching step by GBE.
|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
MODIFY |
Summary: GYS1 is a cytosolic enzyme that associates with glycogen particles. Cytoplasm is correct but non-specific; cytosol (GO:0005829) is the more informative term.
Reason: Cytoplasm is correct but under-specific for this soluble, glycogen-associated enzyme. The GOA set already includes cytosol (GO:0005829) from Reactome/Ensembl, which is the more informative cellular-component assignment.
Propagation Review
Root cause:
TERM SCOPING PROBLEM
Failure modes:
GRANULARITY MISMATCH
Proposed replacements:
cytosol
Supporting Evidence:
PMID:35835870
GYS1 is expressed in most tissues including the muscle and brain7, whereas GYS2 is expressed only in the liver.
|
|
GO:0004373
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assignment of the canonical glycogen synthase activity, consistent with RHEA:18549 / EC 2.4.1.11 and with experimental evidence.
Reason: The IEA mapping (ARBA/RHEA/EC) matches the experimentally established catalytic activity of GYS1 and duplicates the IBA/EXP annotations to the same term.
Supporting Evidence:
PMID:35835870
GYS, a retaining glycosyltransferase (GT) belonging to the GT3 superfamily, catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing end of a growing polysaccharide chain, using UDP-glc as the sugar donor with the release of UDP5.
|
|
GO:0005978
glycogen biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assignment of glycogen biosynthetic process, matching the well-established role of GYS1 and duplicating the IBA/TAS/IDA annotations to the same term.
Reason: Consistent with UniPathway UPA00164 (glycogen biosynthesis) and with experimental evidence for the human enzyme.
Supporting Evidence:
PMID:35835870
Mammalian GYS is the rate-limiting enzyme in glycogen biosynthesis, and its activity is regulated posttranslationally by two mechanisms
|
|
GO:0005515
protein binding
|
IPI
PMID:10481074 A GSK3-binding peptide from FRAT1 selectively inhibits the G... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from an IntAct record; the recorded partner is GSK3B (UniProtKB:P49841), the kinase that phosphorylates and inhibits glycogen synthase.
Reason: Per curation guidelines, the uninformative term "protein binding" does not convey a molecular function and should not be treated as a core annotation. The underlying GYS1-GSK3B relationship (a kinase-substrate interaction) is real, but this paper is about FRAT1/GSK3 and only mentions glycogen synthase as a GSK3 substrate; a specific MF term (e.g. protein kinase binding) would be more informative if experimentally warranted for GYS1 itself.
Supporting Evidence:
PMID:10481074
FRATtide does not suppress GSK3 activity towards other
|
|
GO:0005515
protein binding
|
IPI
PMID:16189514 Towards a proteome-scale map of the human protein-protein in... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI derived from a genome-scale yeast two-hybrid interactome map (CCSB); partner UniProtKB:O15488 (GYG2).
Reason: "protein binding" is uninformative and this is a high-throughput proteome-scale screen. The GYG2 partner is biologically plausible (glycogenin-2), but a bare binding term adds no functional information beyond the specific GYG1/GYG2 complex annotations.
Supporting Evidence:
PMID:16189514
proteome-scale map of the human protein-protein interaction network
|
|
GO:0005515
protein binding
|
IPI
PMID:16282323 Evidence that Ser87 of BimEL is phosphorylated by Akt and re... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI; the IntAct partner is GSK3B (UniProtKB:P49841). The paper concerns Akt phosphorylation of BimEL, not GYS1 function directly.
Reason: Uninformative "protein binding" term; the source is not a study of GYS1 molecular function. Retain as over-annotation rather than a core function.
Supporting Evidence:
PMID:16282323
Ser87 of BimEL is phosphorylated by Akt
|
|
GO:0005515
protein binding
|
IPI
PMID:17055998 Interaction between glycogenin and glycogen synthase. |
MARK AS OVER ANNOTATED |
Summary: IPI recording the physiologically important GYS1-glycogenin (GYG1) interaction, established by yeast two-hybrid using human skeletal muscle. Although annotated as bare "protein binding", this partner (GYG1) is functionally central.
Reason: The interaction itself is genuine and biologically core (GYS1 forms a complex with glycogenin), but the term "protein binding" is uninformative per curation guidelines. This is better captured by the GYS1-GYG1 complex annotation (GO:1902494, part_of catalytic complex) and could support a more specific term such as glucosyltransferase/enzyme complex membership.
Supporting Evidence:
PMID:17055998
Two glycogen synthase-interacting proteins were identified in human
|
|
GO:0005515
protein binding
|
IPI
PMID:24165324 Leucine-rich repeat kinase 2 regulates tau phosphorylation t... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI with partner GSK3B (UniProtKB:P49841); the paper is about LRRK2 activation of GSK-3beta and tau phosphorylation, not GYS1 function.
Reason: Uninformative term and not a study of GYS1 molecular function; keep as over-annotation.
Supporting Evidence:
PMID:24165324
directly associates with GSK-3β
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from a proteome-scale human interactome map (HI-II-14); partners include GYG1 and other proteins from a high-throughput screen.
Reason: Uninformative term from a large-scale interactome dataset; not a core molecular function annotation.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
|
|
GO:0005515
protein binding
|
IPI
PMID:28330616 Systematic Analysis of Human Protein Phosphatase Interaction... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from a systematic phosphatase interactome study; the recorded partner is PPP1R3C/PTG (UniProtKB:Q9UQK1), a glycogen-targeting PP1 regulatory subunit relevant to GYS1 dephosphorylation.
Reason: The GYS1-PPP1R3C relationship is physiologically meaningful (PP1/PTG recruitment to glycogen dephosphorylates and thereby activates GYS1), but "protein binding" is uninformative and derives from a large affinity-proteomics survey. Keep as over-annotation; a more specific term could be warranted with dedicated evidence.
Supporting Evidence:
PMID:28330616
Yet, in contrast to kinases, much less is known about protein
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from the BioPlex human interactome (partner PPP1R3C/Q9UQK1).
Reason: Uninformative term from a proteome-scale affinity-purification interactome; not a core molecular function.
Supporting Evidence:
PMID:28514442
Architecture of the human interactome defines protein communities
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from the HuRI reference binary interactome (many partners from a single high-throughput yeast two-hybrid screen).
Reason: Uninformative term; the numerous partners recorded from this one screen are largely incidental binary hits and do not define GYS1 molecular function.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from BioPlex 3.0 (partners GYG2/O15488 and PPP1R3C/Q9UQK1).
Reason: Uninformative term from a proteome-scale interactome dataset; keep as over-annotation.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human
|
|
GO:0005515
protein binding
|
IPI
PMID:35271311 OpenCell: Endogenous tagging for the cartography of human ce... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from the OpenCell endogenous-tagging interactome (partners include GYG1/GYG2).
Reason: Uninformative term from a systematic cell-organization mapping effort; not a core molecular function.
Supporting Evidence:
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human cellular organization
|
|
GO:0005536
D-glucose binding
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Electronic annotation (from rat ortholog) of D-glucose binding, reflecting the substrate-binding aspect of the transferase; glucose is the moiety transferred from UDP-glucose to the growing chain.
Reason: Plausible as an aspect of the catalytic mechanism (the glucosyl donor is UDP-glucose, and glucose-6-phosphate is an allosteric activator), but this generic sugar-binding term is not the core informative molecular function, which is the glucosyltransferase activity (GO:0004373).
Supporting Evidence:
PMID:35835870
catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing end of a growing polysaccharide chain, using UDP-glc as the sugar donor
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000107 |
MODIFY |
Summary: Electronic (Ensembl ortholog) localization to cytoplasm, consistent with GYS1 being a soluble cytosolic enzyme; cytosol (GO:0005829) is the more specific term.
Reason: Cytoplasm is correct but under-specific; cytosol (GO:0005829), already present in the GOA set from Reactome/Ensembl, is the more informative assignment for this soluble glycogen-associated enzyme.
Proposed replacements:
cytosol
|
|
GO:0005829
cytosol
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: GYS1 acts in the cytosol, where it associates with glycogen particles. This is the correct and informative cellular-component assignment.
Reason: GYS1 has no transmembrane region or signal peptide (UniProt) and is a soluble cytosolic glycogen-synthesizing enzyme; cytosol is the appropriate location.
Supporting Evidence:
PMID:35835870
GYS1 is expressed in most tissues including the muscle and brain7, whereas GYS2 is expressed only in the liver.
|
|
GO:0005977
glycogen metabolic process
|
IEA
GO_REF:0000107 |
MODIFY |
Summary: Broad electronic annotation to glycogen metabolic process; correct but a parent of the more precise glycogen biosynthetic process (GO:0005978) that also annotates GYS1.
Reason: GYS1 is specifically a biosynthetic (glycogen-synthesizing) enzyme, not a catabolic one; the more specific child term glycogen biosynthetic process (GO:0005978) is the informative annotation and is already present.
Proposed replacements:
glycogen biosynthetic process
Supporting Evidence:
PMID:35835870
Mammalian GYS is the rate-limiting enzyme in glycogen biosynthesis, and its activity is regulated posttranslationally by two mechanisms
|
|
GO:0016234
inclusion body
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Electronic annotation (from mouse ortholog) placing GYS1 in inclusion bodies; likely reflects glycogen aggregates / polyglucosan (Lafora-body-type) inclusions with which the enzyme co-localizes when glycogen metabolism is perturbed, rather than a normal resident location.
Reason: Not the physiological site of action of the enzyme; a peripheral/pathology-associated localization retained as non-core rather than as a core cellular component.
Supporting Evidence:
PMID:21356517
deposits containing sparsely branched, insoluble glycogen-like polymers in many tissues, including neurons
|
|
GO:0061547
glycogen synthase activity, transferring glucose-1-phosphate
|
IEA
GO_REF:0000120 |
MARK AS OVER ANNOTATED |
Summary: Electronic annotation of the glucose-1-phosphate-transferring (phosphate-incorporating) activity. Experimentally, GYS1 does introduce the beta-phosphate of UDP-glucose into glycogen, but only as a rare (~1 in 10,000 glucose) catalytic side reaction, not as a physiological function.
Reason: The phosphate-transferring activity is a documented but low-frequency "catalytic error"; presenting it as an enabled molecular function on par with the canonical GO:0004373 activity over-states its biological significance.
Supporting Evidence:
PMID:21356517
the biosynthetic enzyme glycogen synthase, which normally adds glucose residues to glycogen, is capable of incorporating
|
|
GO:0005978
glycogen biosynthetic process
|
TAS
Reactome:R-HSA-3322077 |
ACCEPT |
Summary: Reactome (Glycogen synthesis) traceable assignment of glycogen biosynthetic process; consistent with the core role of GYS1.
Reason: Matches the well-established biological process for GYS1 and duplicates the IBA/IEA/IDA annotations to the same term.
Supporting Evidence:
PMID:35835870
Glycogen synthesis is a multistep process consisting of a priming step by GYG followed by an elongation step carried out by GYS and then a branching step by GBE.
|
|
GO:0004373
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
|
EXP
PMID:19699667 Identification of a novel mutation in GYS1 (muscle-specific ... |
ACCEPT |
Summary: Experimental (Reactome-curated) evidence for the canonical glucosyltransferase activity; this clinical study identified a homozygous GYS1 loss-of-function deletion causing muscle glycogen synthase deficiency and sudden cardiac death.
Reason: Confirms the core catalytic function of GYS1 through a loss-of-function human phenotype (GSD 0b); supports GO:0004373 as the defining activity.
Supporting Evidence:
PMID:19699667
A homozygous two base pair deletion was identified in
|
|
GO:0004373
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
|
EXP
PMID:35835870 Molecular basis for the regulation of human glycogen synthas... |
ACCEPT |
Summary: Direct experimental/structural evidence for the canonical UDP-glucose-dependent alpha-1,4 glucosyltransferase activity of human GYS1, including catalytic activity (RHEA:18549), substrate binding and the catalytically competent state.
Reason: Cryo-EM and enzymatic characterization of human GYS1 directly establish this as the core molecular function.
Supporting Evidence:
PMID:35835870
resulting in a catalytically competent state for extending the associated glycogen chain
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3828061 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (from the "Defective GYS1" GSD 0 reaction context); consistent with GYS1 being a soluble cytosolic enzyme.
Reason: Cytosol is the correct and informative cellular component for this soluble, glycogen-associated enzyme.
|
|
GO:0005978
glycogen biosynthetic process
|
IDA
PMID:35835870 Molecular basis for the regulation of human glycogen synthas... |
ACCEPT |
Summary: ComplexPortal IDA linking the GYS1-glycogenin complex to glycogen biosynthetic process, based on the cryo-EM characterization of the human complex.
Reason: Direct experimental evidence for the involvement of GYS1 (in complex with GYG1) in glycogen biosynthesis; a core process annotation.
Supporting Evidence:
PMID:35835870
Glycogen synthesis is a multistep process consisting of a priming step by GYG followed by an elongation step carried out by GYS and then a branching step by GBE.
|
|
GO:1902494
catalytic complex
|
IDA
PMID:35835870 Molecular basis for the regulation of human glycogen synthas... |
ACCEPT |
Summary: ComplexPortal IDA: GYS1 is part of the catalytic glycogen synthase-glycogenin complex (a GYS1 tetramer with two GYG1 dimers), characterized by cryo-EM.
Reason: Direct experimental/structural evidence establishes GYS1 as a subunit of the GYS1-GYG1 catalytic complex; this is a core, biologically meaningful complex membership.
Supporting Evidence:
PMID:35835870
Cryo-EM map and model of the tetrameric GYS1–GYG1ΔCD complex at 3.0 Å resolution.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3322001 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (GYS1 polyglucosylation of oligoGlc-GYG1).
Reason: Correct informative cytosolic localization for this soluble enzyme; consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3322005 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (branch-formation reaction context with GYS1-a).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3322025 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (autoglucosylation of GYG1 complexed with GYS1-a).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3781001 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (EPM2A/laforin binding to PPP1R3C:phosphoglycogen-GYG1 complex context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3781009 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (NHLRC1-mediated ubiquitination context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3781018 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (EPM2A dephosphorylation of phosphoglycogen-GYG1 context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3781023 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (PPP1R3C binding to glycogen:GYG1:GYS1 context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3781024 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (GYS1 incorporation of phosphoglucose into glycogen-GYG1 context; the phosphate-side-reaction).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3791349 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (defective EPM2A / Lafora disease context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3797226 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (defective NHLRC1 / Lafora disease context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3814838 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (defective GYG1 autoglucosylation context).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0061547
glycogen synthase activity, transferring glucose-1-phosphate
|
EXP
PMID:21356517 Phosphate incorporation during glycogen synthesis and Lafora... |
MARK AS OVER ANNOTATED |
Summary: Experimental evidence that glycogen synthase (including recombinant human GYS1) can transfer the beta-phosphate of UDP-glucose into glycogen, forming glucose C2/C3 phosphomonoesters, at ~1 per 10,000 glucoses. This is the basis of the glucose-1-phosphate-transferring activity term.
Reason: The activity is experimentally real but is explicitly described as a rare deviation from the normal reaction (a "catalytic error"), not a physiological function; it should not be presented as a core enabled molecular function alongside the canonical GO:0004373 activity. Retained as an over-annotation with its supporting EXP evidence.
Supporting Evidence:
PMID:21356517
Glycogen synthase catalyzes the formation of the primary polymerizing α-1,4-glycosidic linkages by transferring a glucosyl moiety from UDP-glucose to a non-reducing end of a glycogen molecule with the release of UDP
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
MARK AS OVER ANNOTATED |
Summary: High-throughput mass-spectrometry detection of GYS1 in a membrane-enriched fraction of an NK-cell line. GYS1 is a soluble cytosolic enzyme with no transmembrane region; the study itself notes that most non-integral hits are only transiently membrane-associated.
Reason: GYS1 has no TM domain or signal peptide (UniProt) and is established as cytosolic. Detection in a membrane proteomics fraction most likely reflects transient/peripheral association (e.g. via glycogen particles) rather than true membrane residency; this is an over-annotation from a large-scale localization screen.
Supporting Evidence:
PMID:19946888
could be predicted to be transiently associated with membranes
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3322003 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (autoglucosylation of GYG1 complexed with GYS1-b).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3322041 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (phosphorylated GYS1 polyglucosylation of oligoGlc-GYG1).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3322057 |
ACCEPT |
Summary: Reactome traceable localization to cytosol (branch formation in polyGlc-GYG1 complexed with GYS1-b).
Reason: Correct cytosolic localization, consistent with the other cytosol annotations.
|
Q: Is the glucose-1-phosphate-transferring (phosphate-incorporating) side reaction of GYS1 physiologically regulated, or is it purely a stochastic catalytic error whose rate is fixed by the enzyme mechanism?
Q: Beyond glycogenin (GYG1) and the PP1 targeting subunits (PPP1R3 family), which of the many high-throughput interactome partners of GYS1 represent bona fide regulatory or scaffolding interactions relevant to glycogen metabolism?
Experiment: Structure-guided mutagenesis of the Glc6P allosteric arginine cluster and the N-/C-terminal phosphorylation sites in human GYS1, coupled with kinetic assays, to quantify the independent contributions of allosteric activation and dephosphorylation to activation of the human enzyme.
Experiment: Cell-based tagging/fractionation of endogenous GYS1 to test whether the reported membrane association is genuine peripheral binding (e.g. via glycogen particles) or a proteomics artifact, and to map its localization relative to glycogen synthesis sites.
UniProtKB:P13807 — Glycogen [starch] synthase, muscle. HGNC:4706. 737 aa. Chr 19.
EC 2.4.1.11. CAZy GT3 (glycosyltransferase family 3). Reactome R-HSA-3322077 (Glycogen synthesis).
id: P13807
gene_symbol: GYS1
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
GYS1 encodes glycogen synthase 1, the muscle (and general non-hepatic) isoform of
glycogen synthase and the committed, rate-limiting elongation enzyme of glycogen
biosynthesis. As a retaining glycosyltransferase of family GT3 (EC 2.4.1.11), it uses
UDP-glucose as the glucosyl donor to add glucose units in alpha-1,4-glycosidic linkage
to the non-reducing ends of a growing glycogen chain that has been primed by glycogenin
(GYG1); glycogen branching enzyme (GBE1) subsequently introduces alpha-1,6 branch points.
GYS1 forms a heterooctameric complex with glycogenin (a GYS1 tetramer bound to two GYG1
dimers). Its activity is tightly regulated: it is allosterically activated by
glucose-6-phosphate and inhibited by hierarchical multi-site phosphorylation of its N-
and C-terminal tails (by kinases including GSK3, AMPK, casein kinase 2, PASK and DYRK2),
which is reversed by glycogen-associated protein phosphatase 1 (recruited by PPP1R3
targeting subunits such as PTG/PPP1R3C). GYS1 is cytosolic and associates with glycogen
particles. In humans, loss-of-function variants cause muscle glycogen storage disease 0
(GSD 0b), characterized by cardiomyopathy, exercise intolerance and risk of sudden
cardiac death.
alternative_products:
- name: '1'
id: P13807-1
- name: '2'
id: P13807-2
sequence_note: VSP_042745
existing_annotations:
- term:
id: GO:0004373
label: alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Canonical, phylogenetically inferred molecular function of glycogen synthase: it
elongates glycogen chains by transferring glucose from UDP-glucose to the alpha-1,4
non-reducing end of the polymer. This is the core catalytic activity of GYS1.
action: ACCEPT
reason: >-
The IBA is well supported by direct experimental evidence for the human enzyme and
by the biochemical literature. This is the defining activity of GYS1 (EC 2.4.1.11).
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
GYS, a retaining glycosyltransferase (GT) belonging to the GT3 superfamily,
catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing
end of a growing polysaccharide chain, using UDP-glc as the sugar donor with the
release of UDP5.
- term:
id: GO:0005978
label: glycogen biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
GYS1 is the elongation enzyme of glycogen biosynthesis, acting together with
glycogenin (priming) and branching enzyme (branching). This is a core biological
process for the gene.
action: ACCEPT
reason: >-
Directly supported by experimental and structural work on human GYS1; the enzyme
catalyzes the rate-limiting elongation step of glycogen synthesis.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
Glycogen synthesis is a multistep process consisting of a priming step by GYG
followed by an elongation step carried out by GYS and then a branching step by GBE.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
GYS1 is a cytosolic enzyme that associates with glycogen particles. Cytoplasm is
correct but non-specific; cytosol (GO:0005829) is the more informative term.
action: MODIFY
reason: >-
Cytoplasm is correct but under-specific for this soluble, glycogen-associated
enzyme. The GOA set already includes cytosol (GO:0005829) from Reactome/Ensembl,
which is the more informative cellular-component assignment.
proposed_replacement_terms:
- id: GO:0005829
label: cytosol
propagation_review:
root_cause: TERM_SCOPING_PROBLEM
failure_modes:
- GRANULARITY_MISMATCH
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
GYS1 is expressed in most tissues including the muscle and brain7, whereas GYS2 is
expressed only in the liver.
- term:
id: GO:0004373
label: alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic assignment of the canonical glycogen synthase activity, consistent with
RHEA:18549 / EC 2.4.1.11 and with experimental evidence.
action: ACCEPT
reason: >-
The IEA mapping (ARBA/RHEA/EC) matches the experimentally established catalytic
activity of GYS1 and duplicates the IBA/EXP annotations to the same term.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
GYS, a retaining glycosyltransferase (GT) belonging to the GT3 superfamily,
catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing
end of a growing polysaccharide chain, using UDP-glc as the sugar donor with the
release of UDP5.
- term:
id: GO:0005978
label: glycogen biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Electronic assignment of glycogen biosynthetic process, matching the well-established
role of GYS1 and duplicating the IBA/TAS/IDA annotations to the same term.
action: ACCEPT
reason: >-
Consistent with UniPathway UPA00164 (glycogen biosynthesis) and with experimental
evidence for the human enzyme.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
Mammalian GYS is the rate-limiting enzyme in glycogen biosynthesis, and its
activity is regulated posttranslationally by two mechanisms
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:10481074
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from an IntAct record; the recorded partner is GSK3B
(UniProtKB:P49841), the kinase that phosphorylates and inhibits glycogen synthase.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Per curation guidelines, the uninformative term "protein binding" does not convey a
molecular function and should not be treated as a core annotation. The underlying
GYS1-GSK3B relationship (a kinase-substrate interaction) is real, but this paper is
about FRAT1/GSK3 and only mentions glycogen synthase as a GSK3 substrate; a specific
MF term (e.g. protein kinase binding) would be more informative if experimentally
warranted for GYS1 itself.
supported_by:
- reference_id: PMID:10481074
supporting_text: >-
FRATtide does not suppress GSK3 activity towards other
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16189514
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI derived from a genome-scale yeast two-hybrid interactome
map (CCSB); partner UniProtKB:O15488 (GYG2).
action: MARK_AS_OVER_ANNOTATED
reason: >-
"protein binding" is uninformative and this is a high-throughput proteome-scale
screen. The GYG2 partner is biologically plausible (glycogenin-2), but a bare
binding term adds no functional information beyond the specific GYG1/GYG2 complex
annotations.
supported_by:
- reference_id: PMID:16189514
supporting_text: >-
proteome-scale map of the human protein-protein interaction network
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16282323
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI; the IntAct partner is GSK3B (UniProtKB:P49841). The
paper concerns Akt phosphorylation of BimEL, not GYS1 function directly.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative "protein binding" term; the source is not a study of GYS1 molecular
function. Retain as over-annotation rather than a core function.
supported_by:
- reference_id: PMID:16282323
supporting_text: Ser87 of BimEL is phosphorylated by Akt
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17055998
qualifier: enables
review:
summary: >-
IPI recording the physiologically important GYS1-glycogenin (GYG1) interaction,
established by yeast two-hybrid using human skeletal muscle. Although annotated as
bare "protein binding", this partner (GYG1) is functionally central.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The interaction itself is genuine and biologically core (GYS1 forms a complex with
glycogenin), but the term "protein binding" is uninformative per curation guidelines.
This is better captured by the GYS1-GYG1 complex annotation (GO:1902494, part_of
catalytic complex) and could support a more specific term such as
glucosyltransferase/enzyme complex membership.
supported_by:
- reference_id: PMID:17055998
supporting_text: >-
Two glycogen synthase-interacting proteins were identified in human
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:24165324
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI with partner GSK3B (UniProtKB:P49841); the paper is about
LRRK2 activation of GSK-3beta and tau phosphorylation, not GYS1 function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term and not a study of GYS1 molecular function; keep as
over-annotation.
supported_by:
- reference_id: PMID:24165324
supporting_text: directly associates with GSK-3β
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from a proteome-scale human interactome map (HI-II-14);
partners include GYG1 and other proteins from a high-throughput screen.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term from a large-scale interactome dataset; not a core molecular
function annotation.
supported_by:
- reference_id: PMID:25416956
supporting_text: A proteome-scale map of the human interactome network
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28330616
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from a systematic phosphatase interactome study; the
recorded partner is PPP1R3C/PTG (UniProtKB:Q9UQK1), a glycogen-targeting PP1
regulatory subunit relevant to GYS1 dephosphorylation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The GYS1-PPP1R3C relationship is physiologically meaningful (PP1/PTG recruitment to
glycogen dephosphorylates and thereby activates GYS1), but "protein binding" is
uninformative and derives from a large affinity-proteomics survey. Keep as
over-annotation; a more specific term could be warranted with dedicated evidence.
supported_by:
- reference_id: PMID:28330616
supporting_text: >-
Yet, in contrast to kinases, much less is known about protein
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from the BioPlex human interactome (partner
PPP1R3C/Q9UQK1).
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term from a proteome-scale affinity-purification interactome; not a
core molecular function.
supported_by:
- reference_id: PMID:28514442
supporting_text: Architecture of the human interactome defines protein communities
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from the HuRI reference binary interactome (many partners
from a single high-throughput yeast two-hybrid screen).
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term; the numerous partners recorded from this one screen are
largely incidental binary hits and do not define GYS1 molecular function.
supported_by:
- reference_id: PMID:32296183
supporting_text: A reference map of the human binary protein interactome
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from BioPlex 3.0 (partners GYG2/O15488 and
PPP1R3C/Q9UQK1).
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term from a proteome-scale interactome dataset; keep as
over-annotation.
supported_by:
- reference_id: PMID:33961781
supporting_text: >-
Dual proteome-scale networks reveal cell-specific remodeling of the human
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35271311
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from the OpenCell endogenous-tagging interactome (partners
include GYG1/GYG2).
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term from a systematic cell-organization mapping effort; not a core
molecular function.
supported_by:
- reference_id: PMID:35271311
supporting_text: >-
OpenCell: Endogenous tagging for the cartography of human cellular organization
- term:
id: GO:0005536
label: D-glucose binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: >-
Electronic annotation (from rat ortholog) of D-glucose binding, reflecting the
substrate-binding aspect of the transferase; glucose is the moiety transferred from
UDP-glucose to the growing chain.
action: KEEP_AS_NON_CORE
reason: >-
Plausible as an aspect of the catalytic mechanism (the glucosyl donor is UDP-glucose,
and glucose-6-phosphate is an allosteric activator), but this generic sugar-binding
term is not the core informative molecular function, which is the glucosyltransferase
activity (GO:0004373).
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing
end of a growing polysaccharide chain, using UDP-glc as the sugar donor
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: located_in
review:
summary: >-
Electronic (Ensembl ortholog) localization to cytoplasm, consistent with GYS1 being
a soluble cytosolic enzyme; cytosol (GO:0005829) is the more specific term.
action: MODIFY
reason: >-
Cytoplasm is correct but under-specific; cytosol (GO:0005829), already present in
the GOA set from Reactome/Ensembl, is the more informative assignment for this
soluble glycogen-associated enzyme.
proposed_replacement_terms:
- id: GO:0005829
label: cytosol
- term:
id: GO:0005829
label: cytosol
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: is_active_in
review:
summary: >-
GYS1 acts in the cytosol, where it associates with glycogen particles. This is the
correct and informative cellular-component assignment.
action: ACCEPT
reason: >-
GYS1 has no transmembrane region or signal peptide (UniProt) and is a soluble
cytosolic glycogen-synthesizing enzyme; cytosol is the appropriate location.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
GYS1 is expressed in most tissues including the muscle and brain7, whereas GYS2 is
expressed only in the liver.
- term:
id: GO:0005977
label: glycogen metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Broad electronic annotation to glycogen metabolic process; correct but a parent of
the more precise glycogen biosynthetic process (GO:0005978) that also annotates GYS1.
action: MODIFY
reason: >-
GYS1 is specifically a biosynthetic (glycogen-synthesizing) enzyme, not a catabolic
one; the more specific child term glycogen biosynthetic process (GO:0005978) is the
informative annotation and is already present.
proposed_replacement_terms:
- id: GO:0005978
label: glycogen biosynthetic process
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
Mammalian GYS is the rate-limiting enzyme in glycogen biosynthesis, and its
activity is regulated posttranslationally by two mechanisms
- term:
id: GO:0016234
label: inclusion body
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: located_in
review:
summary: >-
Electronic annotation (from mouse ortholog) placing GYS1 in inclusion bodies; likely
reflects glycogen aggregates / polyglucosan (Lafora-body-type) inclusions with which
the enzyme co-localizes when glycogen metabolism is perturbed, rather than a normal
resident location.
action: KEEP_AS_NON_CORE
reason: >-
Not the physiological site of action of the enzyme; a peripheral/pathology-associated
localization retained as non-core rather than as a core cellular component.
supported_by:
- reference_id: PMID:21356517
supporting_text: >-
deposits containing sparsely branched, insoluble glycogen-like polymers in many
tissues, including neurons
- term:
id: GO:0061547
label: glycogen synthase activity, transferring glucose-1-phosphate
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation of the glucose-1-phosphate-transferring (phosphate-incorporating)
activity. Experimentally, GYS1 does introduce the beta-phosphate of UDP-glucose into
glycogen, but only as a rare (~1 in 10,000 glucose) catalytic side reaction, not as a
physiological function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The phosphate-transferring activity is a documented but low-frequency "catalytic
error"; presenting it as an enabled molecular function on par with the canonical
GO:0004373 activity over-states its biological significance.
supported_by:
- reference_id: PMID:21356517
supporting_text: >-
the biosynthetic enzyme glycogen synthase, which normally adds glucose residues to
glycogen, is capable of incorporating
- term:
id: GO:0005978
label: glycogen biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322077
qualifier: involved_in
review:
summary: >-
Reactome (Glycogen synthesis) traceable assignment of glycogen biosynthetic process;
consistent with the core role of GYS1.
action: ACCEPT
reason: >-
Matches the well-established biological process for GYS1 and duplicates the
IBA/IEA/IDA annotations to the same term.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
Glycogen synthesis is a multistep process consisting of a priming step by GYG
followed by an elongation step carried out by GYS and then a branching step by GBE.
- term:
id: GO:0004373
label: alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
evidence_type: EXP
original_reference_id: PMID:19699667
qualifier: enables
review:
summary: >-
Experimental (Reactome-curated) evidence for the canonical glucosyltransferase
activity; this clinical study identified a homozygous GYS1 loss-of-function deletion
causing muscle glycogen synthase deficiency and sudden cardiac death.
action: ACCEPT
reason: >-
Confirms the core catalytic function of GYS1 through a loss-of-function human
phenotype (GSD 0b); supports GO:0004373 as the defining activity.
supported_by:
- reference_id: PMID:19699667
supporting_text: >-
A homozygous two base pair deletion was identified in
- term:
id: GO:0004373
label: alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
evidence_type: EXP
original_reference_id: PMID:35835870
qualifier: enables
review:
summary: >-
Direct experimental/structural evidence for the canonical UDP-glucose-dependent
alpha-1,4 glucosyltransferase activity of human GYS1, including catalytic activity
(RHEA:18549), substrate binding and the catalytically competent state.
action: ACCEPT
reason: >-
Cryo-EM and enzymatic characterization of human GYS1 directly establish this as the
core molecular function.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
resulting in a catalytically competent state for extending the associated glycogen
chain
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3828061
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (from the "Defective GYS1" GSD 0 reaction
context); consistent with GYS1 being a soluble cytosolic enzyme.
action: ACCEPT
reason: >-
Cytosol is the correct and informative cellular component for this soluble,
glycogen-associated enzyme.
- term:
id: GO:0005978
label: glycogen biosynthetic process
evidence_type: IDA
original_reference_id: PMID:35835870
qualifier: involved_in
review:
summary: >-
ComplexPortal IDA linking the GYS1-glycogenin complex to glycogen biosynthetic
process, based on the cryo-EM characterization of the human complex.
action: ACCEPT
reason: >-
Direct experimental evidence for the involvement of GYS1 (in complex with GYG1) in
glycogen biosynthesis; a core process annotation.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
Glycogen synthesis is a multistep process consisting of a priming step by GYG
followed by an elongation step carried out by GYS and then a branching step by GBE.
- term:
id: GO:1902494
label: catalytic complex
evidence_type: IDA
original_reference_id: PMID:35835870
qualifier: part_of
review:
summary: >-
ComplexPortal IDA: GYS1 is part of the catalytic glycogen synthase-glycogenin
complex (a GYS1 tetramer with two GYG1 dimers), characterized by cryo-EM.
action: ACCEPT
reason: >-
Direct experimental/structural evidence establishes GYS1 as a subunit of the
GYS1-GYG1 catalytic complex; this is a core, biologically meaningful complex
membership.
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
Cryo-EM map and model of the tetrameric GYS1–GYG1ΔCD complex at 3.0 Å resolution.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322001
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (GYS1 polyglucosylation of oligoGlc-GYG1).
action: ACCEPT
reason: >-
Correct informative cytosolic localization for this soluble enzyme; consistent with
the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322005
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (branch-formation reaction context with
GYS1-a).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322025
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (autoglucosylation of GYG1 complexed with
GYS1-a).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3781001
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (EPM2A/laforin binding to
PPP1R3C:phosphoglycogen-GYG1 complex context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3781009
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (NHLRC1-mediated ubiquitination context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3781018
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (EPM2A dephosphorylation of
phosphoglycogen-GYG1 context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3781023
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (PPP1R3C binding to glycogen:GYG1:GYS1
context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3781024
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (GYS1 incorporation of phosphoglucose into
glycogen-GYG1 context; the phosphate-side-reaction).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3791349
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (defective EPM2A / Lafora disease context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3797226
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (defective NHLRC1 / Lafora disease context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3814838
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (defective GYG1 autoglucosylation context).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0061547
label: glycogen synthase activity, transferring glucose-1-phosphate
evidence_type: EXP
original_reference_id: PMID:21356517
qualifier: enables
review:
summary: >-
Experimental evidence that glycogen synthase (including recombinant human GYS1) can
transfer the beta-phosphate of UDP-glucose into glycogen, forming glucose C2/C3
phosphomonoesters, at ~1 per 10,000 glucoses. This is the basis of the
glucose-1-phosphate-transferring activity term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The activity is experimentally real but is explicitly described as a rare deviation
from the normal reaction (a "catalytic error"), not a physiological function; it
should not be presented as a core enabled molecular function alongside the canonical
GO:0004373 activity. Retained as an over-annotation with its supporting EXP evidence.
supported_by:
- reference_id: PMID:21356517
supporting_text: >-
Glycogen synthase catalyzes the formation of the primary polymerizing
α-1,4-glycosidic linkages by transferring a glucosyl moiety from UDP-glucose to a
non-reducing end of a glycogen molecule with the release of UDP
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: >-
High-throughput mass-spectrometry detection of GYS1 in a membrane-enriched fraction
of an NK-cell line. GYS1 is a soluble cytosolic enzyme with no transmembrane region;
the study itself notes that most non-integral hits are only transiently
membrane-associated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
GYS1 has no TM domain or signal peptide (UniProt) and is established as cytosolic.
Detection in a membrane proteomics fraction most likely reflects transient/peripheral
association (e.g. via glycogen particles) rather than true membrane residency; this is
an over-annotation from a large-scale localization screen.
supported_by:
- reference_id: PMID:19946888
supporting_text: >-
could be predicted to be transiently associated with membranes
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322003
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (autoglucosylation of GYG1 complexed with
GYS1-b).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322041
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (phosphorylated GYS1 polyglucosylation of
oligoGlc-GYG1).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3322057
qualifier: located_in
review:
summary: >-
Reactome traceable localization to cytosol (branch formation in polyGlc-GYG1 complexed
with GYS1-b).
action: ACCEPT
reason: Correct cytosolic localization, consistent with the other cytosol annotations.
core_functions:
- description: >-
Elongation of glycogen chains by transfer of glucose from UDP-glucose to the alpha-1,4
non-reducing end of the growing polymer (the committed, rate-limiting step of glycogen
biosynthesis), acting on a glycogenin-primed chain and in concert with branching enzyme.
molecular_function:
id: GO:0004373
label: alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
directly_involved_in:
- id: GO:0005978
label: glycogen biosynthetic process
locations:
- id: GO:0005829
label: cytosol
in_complex:
id: GO:1902494
label: catalytic complex
supported_by:
- reference_id: PMID:35835870
supporting_text: >-
GYS, a retaining glycosyltransferase (GT) belonging to the GT3 superfamily,
catalyzes successive addition of α-1,4-linked glucose residues to the nonreducing
end of a growing polysaccharide chain, using UDP-glc as the sugar donor with the
release of UDP5.
- reference_id: PMID:35835870
supporting_text: >-
Cryo-EM map and model of the tetrameric GYS1–GYG1ΔCD complex at 3.0 Å resolution.
proposed_new_terms: []
suggested_questions:
- question: >-
Is the glucose-1-phosphate-transferring (phosphate-incorporating) side reaction of GYS1
physiologically regulated, or is it purely a stochastic catalytic error whose rate is
fixed by the enzyme mechanism?
- question: >-
Beyond glycogenin (GYG1) and the PP1 targeting subunits (PPP1R3 family), which of the
many high-throughput interactome partners of GYS1 represent bona fide regulatory or
scaffolding interactions relevant to glycogen metabolism?
suggested_experiments:
- description: >-
Structure-guided mutagenesis of the Glc6P allosteric arginine cluster and the N-/C-terminal
phosphorylation sites in human GYS1, coupled with kinetic assays, to quantify the
independent contributions of allosteric activation and dephosphorylation to activation of
the human enzyme.
- description: >-
Cell-based tagging/fractionation of endogenous GYS1 to test whether the reported membrane
association is genuine peripheral binding (e.g. via glycogen particles) or a proteomics
artifact, and to map its localization relative to glycogen synthesis sites.
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10481074
title: A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed
phosphorylation of axin and beta-catenin.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Study of FRAT1/GSK3 in beta-catenin signaling; only mentions glycogen synthase as a
GSK3 substrate. IntAct records a GYS1-GSK3B binary interaction from it. Not a study of
GYS1 molecular function; supports only a bare "protein binding" over-annotation.
- id: PMID:16189514
title: Towards a proteome-scale map of the human protein-protein interaction network.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Genome-scale yeast two-hybrid interactome (CCSB). Source of a bare "protein binding"
IPI (partner GYG2); high-throughput, uninformative for molecular function.
- id: PMID:16282323
title: Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL
apoptotic function.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Study of BimEL/Akt phosphorylation; the associated GYS1 IntAct entry (partner GSK3B) is
incidental. Not a study of GYS1 function.
- id: PMID:17055998
title: Interaction between glycogenin and glycogen synthase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Establishes the physiologically core GYS1-glycogenin (GYG1) interaction by yeast
two-hybrid in human skeletal muscle and maps the interacting regions. Cited by UniProt
SUBUNIT. Supports complex membership rather than a bare "protein binding" term.
- id: PMID:19699667
title: Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase)
resulting in sudden cardiac death, that is diagnosable from skin fibroblasts.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Human case of a homozygous GYS1 loss-of-function deletion causing muscle glycogen
synthase deficiency and sudden cardiac death (GSD 0b), confirming the essential
glucosyltransferase function of GYS1 through phenotype. Abstract-only in cache.
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale NK-cell membrane proteomics; GYS1 detected in a membrane-enriched fraction.
The study itself flags most non-integral hits as transiently membrane-associated. Basis
of the GO:0016020 membrane over-annotation for a soluble cytosolic enzyme.
- id: PMID:21356517
title: Phosphate incorporation during glycogen synthesis and Lafora disease.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Demonstrates GYS1 can transfer the beta-phosphate of UDP-glucose into glycogen (C2/C3
phosphomonoesters) at ~1 per 10,000 glucoses, a rare catalytic side reaction relevant to
Lafora disease. Basis of GO:0061547; supports treating that term as non-core.
- id: PMID:24165324
title: Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct
activation of glycogen synthase kinase-3β.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Study of LRRK2/GSK-3beta in tau phosphorylation; the GYS1 IntAct entry (partner GSK3B) is
incidental. Not a study of GYS1 function.
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteome-scale human interactome map (HI-II-14). Source of bare "protein binding" IPIs;
high-throughput, uninformative for molecular function.
- id: PMID:28330616
title: Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Systematic phosphatase interactome; records GYS1-PPP1R3C (PTG) binding, a physiologically
meaningful glycogen-targeting PP1 regulatory interaction, but annotated only as bare
"protein binding".
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex proteome-scale interactome (partner PPP1R3C). Bare "protein binding" from a
high-throughput affinity-purification network.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
HuRI binary interactome; many GYS1 partners recorded from a single yeast two-hybrid
screen. Bare "protein binding", uninformative for molecular function.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex 3.0 dual proteome-scale interactome (partners GYG2, PPP1R3C). Bare "protein
binding", high-throughput.
- id: PMID:35271311
title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
OpenCell endogenous-tagging interactome (partners include GYG1/GYG2). Bare "protein
binding" from a systematic cell-organization mapping effort.
- id: PMID:35835870
title: Molecular basis for the regulation of human glycogen synthase by phosphorylation
and glucose-6-phosphate.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Definitive cryo-EM and enzymatic characterization of human GYS1: catalytic activity
(EC 2.4.1.11, RHEA:18549), UDP-glucose donor, alpha-1,4 elongation, allosteric Glc6P
activation, phosphorylation-dependent inhibition, and the GYS1-GYG1 heterooctameric
complex. Full text available; primary source for the core functions.
- id: Reactome:R-HSA-3322001
title: GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1
findings: []
- id: Reactome:R-HSA-3322003
title: Autoglucosylation of GYG1 complexed with GYS1-b
findings: []
- id: Reactome:R-HSA-3322005
title: GBE1 catalyzes branch formation in polyGlc-GYG1 complexed with GYS1-a
findings: []
- id: Reactome:R-HSA-3322025
title: Autoglucosylation of GYG1 complexed with GYS1-a
findings: []
- id: Reactome:R-HSA-3322041
title: Phosphorylated GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1
findings: []
- id: Reactome:R-HSA-3322057
title: GBE1 catalyzes branch formation in polyGlc-GYG1 complexed with GYS1-b
findings: []
- id: Reactome:R-HSA-3322077
title: Glycogen synthesis
findings: []
- id: Reactome:R-HSA-3781001
title: EPM2A dimer binds PPP1R3C:phosphoglycogen-GYG1 complex
findings: []
- id: Reactome:R-HSA-3781009
title: NHLRC1 mediated ubiquitination of EPM2A and PPP1RC3 associated with glycogen-GYG1
findings: []
- id: Reactome:R-HSA-3781018
title: EPM2A dimer dephosphorylates phosphoglycogen-GYG1
findings: []
- id: Reactome:R-HSA-3781023
title: PPP1R3C binds to glycogen:GYG1:GYS1
findings: []
- id: Reactome:R-HSA-3781024
title: GYS1 catalyzes the incorporation of phosphoglucose into glycogen-GYG1
findings: []
- id: Reactome:R-HSA-3791349
title: Defective EPM2A does not dephosphorylate phosphoglycogen (type 2A disease)
findings: []
- id: Reactome:R-HSA-3797226
title: Defective NHLRC1 does not ubiquitinate EPM2A (laforin) and PPP1R3C (PTG)
(type 2B disease)
findings: []
- id: Reactome:R-HSA-3814838
title: Defective GYG1 is not autoglucosyolated
findings: []
- id: Reactome:R-HSA-3828061
title: Defective GYS1 does not transfer glucose to growing glycogen chains
findings: []